Phibro Animal Health (NASDAQ:PAHC) CEO Jack Bendheim Sells 700 Shares

Key Points

• Phibro Animal Health CEO Jack Bendheim sold a total of 700 shares at an average price of $40.03, resulting in a transaction worth $28,021, decreasing his total ownership by 1.72%.
• The company's stock price increased by 2.0% to reach $41.45, amidst strong trading volume, and has varied significantly in the past year with a low of $16.16 and a high of $42.32.
• Phibro Animal Health recently reported quarterly earnings of $0.57 per share, exceeding analysts' expectations and established guidance for FY 2026 at 2.520-2.700 EPS, with a current consensus estimate of 1.95 for the year.

Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) CEO Jack Bendheim sold 700 shares of the firm's stock in a transaction that occurred on Friday, October 17th. The shares were sold at an average price of $40.03, for a total transaction of $28,021.00. Following the completion of the transaction, the chief executive officer directly owned 39,974 shares of the company's stock, valued at approximately $1,600,159.22. The trade was a 1.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Jack Bendheim also recently made the following trade(s):

• On Monday, October 20th, Jack Bendheim sold 16,075 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.38, for a total transaction of $649,108.50.
• On Thursday, September 18th, Jack Bendheim sold 7,022 shares of Phibro Animal Health stock. The shares were sold at an average price of $40.26, for a total transaction of $282,705.72.
• On Wednesday, September 10th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The shares were sold at an average price of $41.29, for a total transaction of $145,340.80.
• On Tuesday, September 9th, Jack Bendheim sold 14,080 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.33, for a total transaction of $567,846.40.

Phibro Animal Health Stock Up 2.0%

Phibro Animal Health stock traded up $0.83 during trading on Tuesday, reaching $41.45. The stock had a trading volume of 362,510 shares, compared to its average volume of 273,963. Phibro Animal Health Corporation has a 52-week low of $16.16 and a 52-week high of $42.32. The business has a 50 day moving average price of $37.26 and a 200 day moving average price of $28.66. The company has a quick ratio of 1.25, a current ratio of 2.76 and a debt-to-equity ratio of 2.46. The stock has a market cap of $1.68 billion, a PE ratio of 35.13, a P/E/G ratio of 1.20 and a beta of 0.83.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its quarterly earnings results on Wednesday, August 27th. The company reported $0.57 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.52 by $0.05. The company had revenue of $378.70 million during the quarter, compared to the consensus estimate of $362.24 million. Phibro Animal Health had a net margin of 3.73% and a return on equity of 32.14%. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. On average, analysts predict that Phibro Animal Health Corporation will post 1.95 EPS for the current year.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 24th. Stockholders of record on Wednesday, September 3rd were given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 1.2%. The ex-dividend date was Wednesday, September 3rd. Phibro Animal Health's payout ratio is currently 40.68%.

Institutional Trading of Phibro Animal Health

Several hedge funds and other institutional investors have recently made changes to their positions in PAHC. Principal Financial Group Inc. lifted its stake in shares of Phibro Animal Health by 2.6% in the first quarter. Principal Financial Group Inc. now owns 101,356 shares of the company's stock valued at $2,165,000 after purchasing an additional 2,573 shares during the period. Jackson Creek Investment Advisors LLC acquired a new stake in shares of Phibro Animal Health in the first quarter valued at about $1,411,000. Hussman Strategic Advisors Inc. lifted its stake in shares of Phibro Animal Health by 20.0% in the first quarter. Hussman Strategic Advisors Inc. now owns 126,000 shares of the company's stock valued at $2,691,000 after purchasing an additional 21,000 shares during the period. Csenge Advisory Group lifted its stake in shares of Phibro Animal Health by 26.4% in the first quarter. Csenge Advisory Group now owns 26,143 shares of the company's stock valued at $558,000 after purchasing an additional 5,456 shares during the period. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Phibro Animal Health in the first quarter valued at about $331,000. Institutional investors and hedge funds own 99.34% of the company's stock.

Analyst Upgrades and Downgrades

PAHC has been the subject of several recent analyst reports. Bank of America boosted their price objective on shares of Phibro Animal Health from $19.00 to $27.00 and gave the stock an "underperform" rating in a research report on Friday, August 29th. Zacks Research raised shares of Phibro Animal Health from a "hold" rating to a "strong-buy" rating in a research report on Monday, September 29th. JPMorgan Chase & Co. raised shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and raised their price objective for the stock from $25.00 to $35.00 in a research report on Monday, July 7th. Morgan Stanley set a $34.00 price objective on shares of Phibro Animal Health in a research report on Thursday, August 28th. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of Phibro Animal Health in a research report on Tuesday, October 14th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company's stock. According to data from MarketBeat, Phibro Animal Health has a consensus rating of "Hold" and an average target price of $28.40.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.